ORCL

Leg	Exchange	Price	Fund. /8h	Each payment	Next in	OI	Vol 24h	Lev
LONG	InjectiveORCL/USDC PERP	138.61	+0.0033	pay 0.0004% / 1h	53m 25s	$27K	$101K	10x	Long Injective
SHORT	PopdexORCLUSDT	139.10	+0.0048	get 0.0006% / 1h	53m 25s	$359K	$171K	20x	Short Popdex

Price gap+0.354%

Funding gap+0.0015% /8h

Both sides work: funding pays $0 a day on $10k, and the gap is 0.508% above its 7d average: +$51 more if it goes back.

If you open now and hold

on $10k a leg · figures of the last 7D, not a forecast

Funding+$5+0.0015% /8h now · paid +0.050% over the last 6 days (all we have)

Price+$51spread +0.354% now, avg −0.155% → +0.508% if it goes back

Costsdoesn’t fit$10k a leg is deeper than the books hold

Result, before costs+$56+0.56%no pointscosts unknown: book too thin at $10k · What the last 7D really paid, hour by hour → backtest

Funding history

you earnyou payavg

RANGE STATS · 7D

Average /8h—

Highest—

Lowest—

Paid you—

Short leg rate minus long leg rate, per 8h. Above zero: the pair pays you.

Price spread between the two exchanges

Popdex price against Injectivenow

RANGE STATS · 7D

Now+0.354%

Average—

Range—

Wider than now—

Where the spread has been, last 7D

share of time at each level

Funding on every exchange

/8h

ORCL on 29 exchanges

lowest funding first

Before you open

3 ok · 2 to watch

Problem: Doesn’t fit the books—
$10k a leg is deeper than Injective’s order book right now.
Note: Margin at max leverage$1,000 + $500
Injective 10x, Popdex 20x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
OK: Same payment interval1h / 1h
Both legs pay at the same time.
Next 24h at the current rates, on $10k a leg: +$0.44Long Injective: 24 payments, −$1.00; short Popdex: 24 payments, +$1.44.
OK: Entry gap works for you+0.354% vs −0.155%
You short the dearer leg. If the gap goes back to average, the short gains.
Watch: Long leg is thinner$27K vs $359K OI
Injective sets your exit cost. Check its book before closing.
Note: No points program—
Neither exchange runs points right now.
OK: No KYC on either legInjective No · Popdex No
Both exchanges let you trade without ID.

Profit calculator

both legs, in and out

Position, each leg

Hold for

Orders

Price spread

Funding rate

Funding earned+0.0028%/8h × 21 periods+$5.92

Price spread+0.354% → −0.155% (7d avg)+$50.82

Slippage, 4 ordersdoesn’t fit the book at $10k—

Fee Injective bp × 2 orders−$0.02

Fee Popdex bp × 2 orders−$6.40

Net · 7 days · $10k—

doesn’t fit the books at $10k

Costs to cover—Break-even—

Slippage: Injective: live order book, 61 min ago; Popdex: live order book, 30 min ago

Cost to enter

taker + slippage from mid, one side

BUY · LONGInjective30.16doesn’t fitdoesn’t fitdoesn’t fitdoesn’t fit

SELL · SHORTPopdex1.087.6 bp−$844.7 bp−$447doesn’t fitdoesn’t fit

Closing costs about the same again.

ORCL news

posts that mention ORCL or Oracle, from every exchangeSearch all news →

09-29 19:30	Vest Markets	Other	Trade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital at: @VestExchange on X ↗
09-29 19:30	Vest Markets	Other	Heading into the close, $ORCL is up around 4.2% with the launch of Fusion Claw, which adds 25 agentic applications. The company also introduced a native NetApp storage service on its cloud, with a full rollout planned within 12 months. The move puts the shares on pace to snap a four-day losing streak that had taken them about 11% lower. @VestExchange on X ↗
09-28 17:30	Vest Markets	Other	Oracle's AI financing model is drawing fresh skepticism, with $ORCL down around 2.7% on the session. S&P lowered the credit rating to BBB-, the shares drew a Sell rating this morning, and five-year default swaps reached a record 227 basis points last week. The $18B of debt tied to Project Jupiter is quoted near 89 cents on the dollar, with about half of Oracle's $664B backlog tied to OpenAI. @VestExchange on X ↗
09-27 09:40	Kalshi	Other	JUST IN: Oracle reportedly gave Larry Ellison and co-CEOs nearly $1 billion in stock options that "had no value" by fiscal year-end @Kalshi on X ↗
09-25 03:59	Kalshi	Other	JUST IN: Oracle's "investment grade" bond closed at 8.10%, in line with B3/B- junk @Kalshi on X ↗
09-24 13:30	Vest Markets	Other	$ORCL is down around 5.4% into the open, with a reported force majeure notice to its New Mexico data center developer. The notice goes to developer Blue Owl on Project Jupiter, seeking to defer payments if the 1,400-acre campus behind Oracle's OpenAI capacity deal slips past 2028. Trade $ORCL volatility with a Vest Capital funded account and access up to $25k in trading capital. @VestExchange on X ↗